A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (CPMP)
Osteoarthritis, Knee, Diabetic Neuropathic Pain, Chronic Low-back Pain
About this trial
This is an interventional screening trial for Osteoarthritis, Knee
Eligibility Criteria
Inclusion Criteria: have a visual analog scale (VAS) pain value >40 and <95 at screening and prerandomization screening. have a history of daily pain for at least 12 weeks based on participant report or medical history have a value of ≤30 on the pain catastrophizing scale have a body mass index <40 kilogram/square meter (kg/m²) (inclusive) are willing to maintain a consistent regimen of any ongoing nonpharmacologic pain-relieving therapies (for example, physical therapy) and will not start any new nonpharmacologic pain-relieving therapies during study participation. are willing to discontinue all medications taken for chronic pain conditions, except rescue medication for the duration of the study Exclusion Criteria: have second- or third-degree atrioventricular (AV) heart block or AV dissociation or history of ventricular tachycardia have had a procedure within the past 6 months intended to produce permanent sensory loss in the target area of interest (for example, ablation techniques) have surgery planned during the study for any reason, related or not to the disease state under evaluation. have, in the judgment of the investigator, an acute, serious, or unstable medical condition or a history or presence of any other medical illness that would preclude study participation. have had cancer within 2 years of baseline, except for cutaneous basal cell or squamous cell carcinoma resolved by excision. have fibromyalgia have substance use disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders (5th edition; DSM-5; American Psychiatric Association) have any clinically important abnormality at screening, as determined by investigator, in physical or neurological examination, vital signs, electrocardiogram (ECG), or clinical laboratory test results that could be detrimental to the participant or could compromise the study. have a positive human immunodeficiency virus (HIV) test result at screening have a history of alcohol, illicit drug, analgesic or narcotic use disorder within 2 years prior to screening.
Sites / Locations
- Simon Williamson Clinic
- Synexus Clinical Research - Glendale
- Central Phoenix Medical ClinicRecruiting
- Arizona Research CenterRecruiting
- Alliance for Multispecialty Research, LLC
- Irvine Clinical Research
- Artemis Institute for Clinical ResearchRecruiting
- Artemis Institute for Clinical ResearchRecruiting
- CMR of Greater New Haven, LLCRecruiting
- VIN-Julie Schwartzbard
- Accel Research Sites- Clinical Research UnitRecruiting
- Encore Research Group- Jacksonville Center for Clinical Research
- Suncoast Research GroupRecruiting
- University of Miami Don Suffer Clinical Research BuildingRecruiting
- New Horizon Research CenterRecruiting
- Renstar Medical ResearchRecruiting
- Synexus Clinical Research US, Inc.Recruiting
- Synexus Clinical Research - St. PetersburgRecruiting
- Martin E. Hale M.D., P.A.
- Synexus Clinical Research US, Inc.
- North Georgia Clinical ResearchRecruiting
- Rocky Mountain Clinical ResearchRecruiting
- Synexus Clinical Research
- Northwestern UniversityRecruiting
- Cotton O'Neil Clinical Research Center - Central Office
- Boston Clinical TrialsRecruiting
- ActivMed Practices and ResearchRecruiting
- MedVadis Research CorporationRecruiting
- Great Lakes Research Group, Inc.Recruiting
- StudyMetrix ResearchRecruiting
- Clinvest Research LLCRecruiting
- Synexus Clinical Research US, Inc.
- PharmQuest
- Lillestol ResearchRecruiting
- Synexus - Cincinnati
- Aventiv Research Inc
- META Medical Research InstituteRecruiting
- Altoona center for clinical researchRecruiting
- Clinical Research Center of Reading,LLC
- Coastal Carolina Research Center
- FutureSearch Trials of NeurologyRecruiting
- Synexus
- Cedar Health Research
- Synexus Clinical Research US, Inc.Recruiting
- SYNEXUS
- Northwest Clinical Research CenterRecruiting
- Rainier Clinical Research CenterRecruiting
- Ponce Medical School Foundation Inc.Recruiting
- Latin Clinical Trial CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Arm 8
Arm 9
Arm 10
Arm 11
Arm 12
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
LY3016859 Osteoarthritis ISA
LY3016859 Diabetic Neuropathic Pain ISA
LY3016859 Chronic Back Pain ISA
LY3556050 Osteoarthritis ISA
LY3556050 Diabetic Neuropathic Pain ISA
LY3556050 Chronic Back Pain ISA
LY3526318 Osteoarthritis ISA
LY3526318 Diabetic Neuropathic Pain ISA
LY3526318 Chronic Back Pain ISA
LY3857210 Osteoarthritis ISA
LY3857210 Diabetic Neuropathic Pain ISA
LY3857210 Chronic Back Pain ISA
Participants are randomized to receive either active LY3016859 or matching placebo
Participants are randomized to receive either active LY3016859 or matching placebo
Participants are randomized to receive either active LY3016859 or matching placebo
Participants are randomized to receive either active LY3556050 or matching placebo
Participants are randomized to receive either active LY3556050 or matching placebo
Participants are randomized to receive either active LY3556050 or matching placebo
Participants are randomized to receive either active LY3526318 or matching placebo
Participants are randomized to receive either active LY3526318 or matching placebo
Participants are randomized to receive either active LY3526318 or matching placebo
Participants are randomized to receive either active LY3857210 or matching placebo
Participants are randomized to receive either active LY3857210 or matching placebo
Participants are randomized to receive either active LY3857210 or matching placebo